Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing safety and tolerability of MEDI0382 in overweight/obese participants with Type 2 Diabetes Mellitus has completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MEDI0382

Snippet

Sponsor: MedImmune LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2020-06-05